Bronchitol poor sales still a major thorn imo
Operational savings but at what cost to revenue and the milestone of cashflow positive
Choice of Distributors and perhaps market research failing badly imo
Or Covid having major effect! even more so than expected
anyone do some research into that scar treatment ‘competition’ which they would be happy to share
Ann: Investor presentation, page-11
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.2¢ |
Change
0.002(5.00%) |
Mkt cap ! $57.67M | |||
| Open | High | Low | Value | Volume |
| 4.0¢ | 4.3¢ | 4.0¢ | $48.01K | 1.160M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1025000 | 3.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.2¢ | 461843 | 2 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| SNT (ASX) Chart |